San Diego-based Ascus Biosciences, an animal health and nutrition company, has raised $46 million in Series B funding. Temasek led the round with participation from other investors that included Anterra Capital, Formation 8 and Cavallo Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: